Media Coverage

A ‘Credit-Score-Like’ Risk Assessment System for Investigative Drugs

6/2/2026
Published in Bio-IT World
A ‘Credit-Score-Like’ Risk Assessment System for Investigative Drugs
A ‘Credit-Score-Like’ Risk Assessment System for Investigative Drugs

Fail fast is not a cultural problem. It is a capital allocation problem.

4/15/2026
Published in Pharmaphorum
Fail fast is not a cultural problem. It is a capital allocation problem.
Fail fast is not a cultural problem. It is a capital allocation problem.

Spotlight On FDA’s One-Trial Shift Pushing Risk Upstream

3/10/2026
Published in First Word Pharma
Spotlight On FDA’s One-Trial Shift Pushing Risk Upstream
Spotlight On FDA’s One-Trial Shift Pushing Risk Upstream

Enabling the translational gap with AI

1/26/2026
Posted in Drug Discovery News
Enabling the translational gap with AI
Enabling the translational gap with AI

How AI-Driven Integration of Data Improves Preclinical Studies, Reduces Drug Trial Failures

1/14/2026
Published in American Journal of Managed Care
How AI-Driven Integration of Data Improves Preclinical Studies, Reduces Drug Trial Failures
How AI-Driven Integration of Data Improves Preclinical Studies, Reduces Drug Trial Failures

How Technology is Moving the Industry Away from Animal Testing: Q&A with Dr. Jo Varshney

11/25/2025
Published in Pharmaceutical Executive
How Technology is Moving the Industry Away from Animal Testing: Q&A with Dr. Jo Varshney
How Technology is Moving the Industry Away from Animal Testing: Q&A with Dr. Jo Varshney

A Future Beyond Animal Testing: Why ORIVA Matters and How Computational Models Bridge the Gap

11/14/2025
Published in GEN (Genetic Engineering & Biotechnology News)
A Future Beyond Animal Testing: Why ORIVA Matters and How Computational Models Bridge the Gap
A Future Beyond Animal Testing: Why ORIVA Matters and How Computational Models Bridge the Gap

AI now develops drugs faster than humans. Is that a good thing?

11/4/2025
Published in LAist/AirTalk by NPR
AI now develops drugs faster than humans. Is that a good thing?
AI now develops drugs faster than humans. Is that a good thing?

Can Patients Trust a Drug Designed By AI?

11/4/2025
Published in Technology Networks
Can Patients Trust a Drug Designed By AI?
Can Patients Trust a Drug Designed By AI?

How AI Is Transforming Drug Development: Jo Varshney, PhD, DVM

10/31/2025
Published in American Journal of Managed Care
How AI Is Transforming Drug Development: Jo Varshney, PhD, DVM
How AI Is Transforming Drug Development: Jo Varshney, PhD, DVM

How Do We Build Trust and Transparency in AI?

10/14/2025
Published in The Medicine Maker
How Do We Build Trust and Transparency in AI?
How Do We Build Trust and Transparency in AI?

AI is reshaping drug discovery - Now it must prove it can be trusted

10/9/2025
Published in Pharmaphorum
AI is reshaping drug discovery - Now it must prove it can be trusted
AI is reshaping drug discovery - Now it must prove it can be trusted

From preclinical to clinic faster with mechanistic modeling and AI

9/23/2025
Published in Drug Discovery News
From preclinical to clinic faster with mechanistic modeling and AI
From preclinical to clinic faster with mechanistic modeling and AI

Hybrid AI Is Reshaping Drug Development—But Will Transparency Be the Ultimate Proof of Safety?

8/20/2025
Published in Marksmen Daily
Hybrid AI Is Reshaping Drug Development—But Will Transparency Be the Ultimate Proof of Safety?
Hybrid AI Is Reshaping Drug Development—But Will Transparency Be the Ultimate Proof of Safety?

VeriSIM delivering predictive insights to advance and de-risk drug development

6/24/2025
Published in BioTuesdays
VeriSIM delivering predictive insights to advance and de-risk drug development
VeriSIM delivering predictive insights to advance and de-risk drug development